It is upregulated in gliomas and correlates with patient survival [9]; moreover, knockdown of HMGA1 suppresses the stemness of glioma stem cells and increases their sensitivity to temozolomide (TMZ) [29, 30]. Here, HMGA1 is linked to central nervous system cancer.